M/s Bio-med Pvt. Ltd.



Quick Contact

M/s Bio-med Pvt. Ltd.

Address : C-96, B. S. Rd. Industrial Area, Ghaziabad, Uttar Pradesh - 201009

Country : India

Phone No : +91-120-4157534, +91-120-4159857

Mobile No : +91-9891707451

Fax : +91-120-4340219

Call Us : 08042754597

Get Adobe Flash Player

English    Czech  French  Hindi  

Typhoid Vi Conjugate Vaccine I.P.

Home » Pharmaceutical Products » Human Vaccines » Typhoid Vaccines » Vi Conjugate Typhoid Vaccine » Typhoid Vi Conjugate Vaccine I.P.


Typhoid Vi Conjugate Vaccine I.P.

Typhoid Vi Conjugate Vaccine I.P. PedaTyph

A clear to slightly turbid solution containing purified Vi capsular polysaccharide of Salmonellatyphi (Strain Ty2) conjugated with Tetanus toxoid protein for prevention of typhoid fever. PedaTyph™ is manufactured as per Indian Pharmacopoeia.The manufacturing facilities meets the specifications as per cGMP guidelines of revised schedule ‘M’ of the Drugs & Cosmetic Act, Government of India.

COMPOSITION

 One dose (0.5 ml) contains:

5 µg of Vi polysaccharide of Salmonella typhi (Strain Ty2) conjugated to 5 µg Tetanus toxoid protein in isotonic saline 0.5 ml.

INDICATIONS

 PedaTyphTM is indicated for active immunization against Salmonella typhi in infants of age >3 months, children and adults.

PRESENTATION

·       One dose in glass vial with disposable Syringe.

 

·       One dose in prefilled syringe .

SHELF LIFE

The shelf life of the product is 36 months from the date of manufacture if stored at recommended storage conditions.

References :-

1.   Garg P., Garg S., Sharma M.K (2014) Clinical trial of Tetanus Toxoid Conjugated Vi Polysaccharide Typhoid Vaccine in infants and young children.

Sharma et al (2014) Biotechnology International 7(4) : 90-100.

2.   Chinnasami B., Mangayarkarasi V., Prema A., Sadasivam K. & Davis M.J. (2013).

     Safety and immunogenicity of Salmonella typhi Vi conjugate vaccine (PedaTyph™) is children upto five years.        International Journal of Scientific and Research Publication, Volume 3, issue 2, February 2013.

3.   Chinnasami B., Sadasivam K., Vivekanandhan A., Arunachalam P. &Pasupathy S. (2015).

A study on Longevity of Immune Response after vaccination with Salmonella typhi Vi Conjugate Vaccine (PedaTyph™) in children. Journal of Clinical & Diagnostic Research. 2015 May, Vol-9(5): SC01-SC03.

4.  Mitra M., Shah N., Ghosh A., et al (2015).

 

Efficacy and Safety of Vi-Tetanus Toxoid Conjugated Typhoid Vaccine (PedaTyphTM) in Indian Children: School Based Cluster Randomized Study.Human Vaccines &immunotherapeutics 2016, Vol.0, No.0, 1-7



© Copyright 2012. M/s Bio-Med Pvt. Ltd.  Managed By ExportersIndia.Com